Pangen Biotech Inc.
Develops and manufactures biopharmaceuticals and offers CDMO services.
222110 | KO
Overview
Corporate Details
- ISIN(s):
- KR7222110009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 신원로 306, 2동 4층(원천동 영통이노플렉스) , 수원시
- Sector:
- Manufacturing
Description
Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-02-22 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 26.1 KB | ||
| 2021-02-01 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.2 KB | ||
| 2021-01-20 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 9.4 KB | ||
| 2020-12-16 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 27.3 KB | ||
| 2020-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2020-11-23 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 28.6 KB | ||
| 2020-11-23 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 101.3 KB | ||
| 2020-11-19 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 10.0 KB | ||
| 2020-11-19 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 10.2 KB | ||
| 2020-11-13 00:00 |
분기보고서 (2020.09)
|
Korean | 965.0 KB | ||
| 2020-11-04 00:00 |
투자판단관련주요경영사항(A형 혈우병 치료제 PGA40의 국내 임상 1상 시험 결과(임상시험결과보고서 수령))
|
Korean | 10.9 KB | ||
| 2020-11-03 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 19.4 KB | ||
| 2020-10-16 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2020-09-28 00:00 |
기타경영사항(특허권취득)(자율공시)(인간 및 마우스 Sema3A에 교차 결합하는 항체 및 그의 용도)
|
Korean | 6.0 KB | ||
| 2020-08-24 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 32.0 KB |
Automate Your Workflow. Get a real-time feed of all Pangen Biotech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pangen Biotech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pangen Biotech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
